UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Potent MCH-1 receptor antagonists from cis-1,4-diaminocyclohexane-derived indane analogs

Bioorganic & medicinal chemistry letters, 2013-07, Vol.23 (14), p.4216-4220

2013

Volltextzugriff (PDF)

Novel glucokinase activators: a patent review (2008 - 2010)

Expert opinion on therapeutic patents, 2011-01, Vol.21 (1), p.13-33

2011

Volltextzugriff (PDF)

Very late antigen-4 integrin antagonists

Expert opinion on therapeutic patents, 2008-08, Vol.18 (8), p.841-859

Tilley, Jefferson W

2008

Volltextzugriff (PDF)

Glucokinase activators as new type 2 diabetes therapeutic agents

Expert opinion on therapeutic patents, 2008-07, Vol.18 (7), p.759-768

2008

Volltextzugriff (PDF)

Identification of N-acyl 4-(5-pyrimidine-2,4-dionyl)phenylalanine derivatives and their orally active prodrug esters as dual-acting alpha4–beta1 and alpha4–beta7 receptor antagonists

Bioorganic & medicinal chemistry letters, 2013-02, Vol.23 (4), p.1026-1031

2013

Volltextzugriff (PDF)

Glucokinase activators: Novo Nordisk's WO2008084044 and Array Biopharma's WO2008091770

Expert opinion on therapeutic patents, 2009-04, Vol.19 (4), p.549-553

Tilley, Jefferson W

2009

Volltextzugriff (PDF)

Identification of N-acyl 4-(3-pyridonyl)phenylalanine derivatives and their orally active prodrug esters as dual acting α4β1 and α4β7 receptor antagonists

Bioorganic & medicinal chemistry letters, 2013-02, Vol.23 (4), p.1036-1040

2013

Volltextzugriff (PDF)

Discovery of camphor-derived pyrazolones as 11β-hydroxysteroid dehydrogenase type 1 inhibitors

Bioorganic & medicinal chemistry letters, 2014-06, Vol.24 (12), p.2707-2711

2014

Volltextzugriff (PDF)

The discovery of VLA-4 antagonists

Current topics in medicinal chemistry, 2004-01, Vol.4 (14), p.1509

2004

Volltextzugriff (PDF)

VLA-4 antagonists

Expert opinion on therapeutic patents, 2002-07, Vol.12 (7), p.991-1008

Tilley, Jefferson W

2002

Volltextzugriff (PDF)

Discovery of 2‑[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of Dyslipidemia

Journal of medicinal chemistry, 2014-05, Vol.57 (10), p.3912-3923

2014

Volltextzugriff (PDF)

Potent, selective MCH-1 receptor antagonists

Bioorganic & medicinal chemistry letters, 2008-02, Vol.18 (4), p.1402-1406

2008

Volltextzugriff (PDF)

Identification of a Small Molecule Inhibitor of the IL-2/IL-2Rα Receptor Interaction Which Binds to IL-2

Journal of the American Chemical Society, 1997-08, Vol.119 (32), p.7589-7590

1997

Volltextzugriff (PDF)

Metabolic/endocrine system

Drug discovery today. Therapeutic strategies, 2007-06, Vol.4 (2), p.101-102

2007

Volltextzugriff (PDF)

The design and synthesis of potent cyclic peptide VCAM-VLA-4 antagonists incorporating an achiral Asp-Pro mimetic

Bioorganic & medicinal chemistry letters, 2000-06, Vol.10 (11), p.1171-1173

2000

Volltextzugriff (PDF)

Imide and lactam derivatives of N-benzylpyroglutamyl- l-phenylalanine as VCAM/VLA-4 antagonists

Bioorganic & medicinal chemistry letters, 2001-01, Vol.11 (1), p.1-4

2001

Volltextzugriff (PDF)

Abstract 2643: Design and discovery of novel oral INV-88 macrophage migration inhibitory factor (MIF) inhibitors: Potent anti-tumor activity in vitro and in vivo

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2643-2643

2022

Volltextzugriff (PDF)

Focused library approach for identification of new N-acylphenylalanines as VCAM/VLA-4 antagonists

Bioorganic & medicinal chemistry letters, 2002-06, Vol.12 (12), p.1679-1682

2002

Volltextzugriff (PDF)

N-Aroyl- l-Phenylalanine Derivatives as VCAM/VLA-4 Antagonists

Bioorganic & medicinal chemistry letters, 2002-09, Vol.12 (17), p.2479-2482

2002

Volltextzugriff (PDF)

N-Benzylpyroglutamyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists

Bioorganic & medicinal chemistry letters, 2000-04, Vol.10 (8), p.729-733

2000

Volltextzugriff (PDF)

N-Acyl phenylalanine analogues as potent small molecule VLA-4 antagonists

Bioorganic & medicinal chemistry letters, 2000-04, Vol.10 (8), p.725-727

2000

Volltextzugriff (PDF)

A convenient palladium-catalyzed coupling approach to 2,5-disubstituted pyridines

Journal of organic chemistry, 1988-01, Vol.53 (2), p.386-390

1988

Volltextzugriff (PDF)

N-Cycloalkanoyl- l-Phenylalanine Derivatives as VCAM/VLA-4 Antagonists

Bioorganic & medicinal chemistry letters, 2002-09, Vol.12 (17), p.2475-2478

2002

Volltextzugriff (PDF)

ChemInform Abstract: Functionalized Organozinc Reagents in Medicinal Chemistry: Discovery of Novel Drug Candidates

ChemInform, 2014-05, Vol.45 (18), p.no-no

2014

Volltextzugriff (PDF)

Cyclic thioether peptide mimetics as VCAM-VLA-4 antagonists

Bioorganic & medicinal chemistry letters, 2000-06, Vol.10 (11), p.1167-1169

2000

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Englisch
(92)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Chemistry
(41)
Life Sciences & Biomedicine
(41)
Chemistry, Medicinal
(35)
Pharmacology & Pharmacy
(35)
Physical Sciences
(33)
Chemistry, Organic
(25)
Animals
(24)
Structure-Activity Relationship
(21)
Humans
(19)
Organic Chemistry
(19)
Rats
(18)
Exact Sciences And Technology
(14)
Biological And Medical Sciences
(13)
Preparations And Properties
(13)
Male
(12)
Medical Sciences
(12)
Pharmacology. Drug Treatments
(11)
Integrins - Antagonists & Inhibitors
(9)
Dogs
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Potent MCH-1 receptor antagonists from cis-1,4-diaminocyclohexane-derived indane analogs

Novel glucokinase activators: a patent review (2008 - 2010)

Very late antigen-4 integrin antagonists

Glucokinase activators as new type 2 diabetes therapeutic agents

Identification of N-acyl 4-(5-pyrimidine-2,4-dionyl)phenylalanine derivatives and their orally active prodrug esters as dual-acting alpha4–beta1 and alpha4–beta7 receptor antagonists

Glucokinase activators: Novo Nordisk's WO2008084044 and Array Biopharma's WO2008091770

Identification of N-acyl 4-(3-pyridonyl)phenylalanine derivatives and their orally active prodrug esters as dual acting α4β1 and α4β7 receptor antagonists

Discovery of camphor-derived pyrazolones as 11β-hydroxysteroid dehydrogenase type 1 inhibitors

The discovery of VLA-4 antagonists

VLA-4 antagonists

Discovery of 2‑[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of Dyslipidemia

Potent, selective MCH-1 receptor antagonists

Identification of a Small Molecule Inhibitor of the IL-2/IL-2Rα Receptor Interaction Which Binds to IL-2

Metabolic/endocrine system

The design and synthesis of potent cyclic peptide VCAM-VLA-4 antagonists incorporating an achiral Asp-Pro mimetic

Imide and lactam derivatives of N-benzylpyroglutamyl- l-phenylalanine as VCAM/VLA-4 antagonists

Abstract 2643: Design and discovery of novel oral INV-88 macrophage migration inhibitory factor (MIF) inhibitors: Potent anti-tumor activity in vitro and in vivo

Focused library approach for identification of new N-acylphenylalanines as VCAM/VLA-4 antagonists

N-Aroyl- l-Phenylalanine Derivatives as VCAM/VLA-4 Antagonists

N-Benzylpyroglutamyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists

N-Acyl phenylalanine analogues as potent small molecule VLA-4 antagonists

A convenient palladium-catalyzed coupling approach to 2,5-disubstituted pyridines

N-Cycloalkanoyl- l-Phenylalanine Derivatives as VCAM/VLA-4 Antagonists

ChemInform Abstract: Functionalized Organozinc Reagents in Medicinal Chemistry: Discovery of Novel Drug Candidates

Cyclic thioether peptide mimetics as VCAM-VLA-4 antagonists

Suchergebnisse filtern